Best Complex diagnostics of thyroid doctors: TOP 47 doctors

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Education

• Undergraduate: Çukurova University, Faculty of Medicine 1992-1998
• Specialty Education: Istanbul Training and Research Hospital 1998-2003
• Subspecialization: IU Istanbul Faculty of Medicine 2004-2007
•  

Experience

• Istanbul Training and Research Hospital 1998-2003
• IU Istanbul Faculty of Medicine 2004-2007
• Istanbul Training and Research Hospital 2007-2009
• Şanlıurfa Training and Research Hospital 2009-2011
• Bağcılar Training and Research Hospital August 2011- November 2011
• Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases December 2011- 2014
• Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases 2014-2020
• Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolic Diseases 2020-2024

Scientific Memberships
 

• Turkish Society of Endocrinology and Metabolic Diseases (Vice President)
• European Society of Endocrinology;
• Endosociety

Awards

1. 1. Bestclinical scientific publication support award (53rd National Diabetes Congress, 2017)
2. 2. 54th National Diabetes Congress (2018) with the study titled "The effects of adding pre-probiotics to the diets of patients with gastric bypass (GBP) on metabolic parameters, icretin levels and hunger, satiety and appetite scores of patients".

Medical Intrests

• Diabetes
• Thyroid diseases (hypothyroidism, hyperthyroidism, thyroid nodules)
• Pituitary diseases
• Adrenal gland diseases
• Osteoporosis

Dr. Victor Alexander Krol - Chief of Gastroenterology, Internal Medicine and Obesity Treatment Center at Martinus Hospital

Dr. Victor Alexander Krol is a highly qualified specialist, heading the departments of gastroenterology and internal medicine. With many years of experience and deep knowledge in his field, Dr. Krol has established himself as an outstanding expert, providing patients with comprehensive treatment and an individual approach. He actively uses the latest methods of diagnosis and treatment of diseases of the gastrointestinal tract, metabolism, as well as diseases of the cardiovascular and respiratory systems.

Dr. Krol is also the director of the certified Obesity Treatment Center at Martinus Hospital, which provides surgical and endoscopic treatments for obesity. The center uses advanced technology to diagnose and treat obesity (adiposis), including methods such as bariatric surgery, endoscopic weight loss, and specialized programs for patients with different stages of obesity. The center is certified to high standards and has excellent results in the treatment of this serious disease.

The Gastroenterology Department, headed by Dr. Krol, diagnoses and treats diseases of the stomach, intestines, liver, pancreas, and gallbladder. The doctors of the department use a wide range of methods, including endoscopic procedures, ultrasound, and other modern diagnostic technologies.

The Department of Internal Medicine covers a wide range of diseases, including cardiology, diabetology, infectology, and therapy of respiratory and renal diseases. Dr. Krol and his team provide a comprehensive approach to treatment using the most advanced methods of medicine.

Thanks to his high professionalism and humane approach to each patient, Dr. Krol deservedly enjoys the respect of colleagues and patients.

Education:

• Degree: Faculty of Medicine, Trakya University, 2009
• Medical Specialty: Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, 2010-2014
• Specialist Doctor: Internal Medicine, Kanuni Sultan Süleyman Training and Research Hospital, 2014-2019
• Specialist Doctor: Internal Medicine, Turkish Hospital Internal Medicine Clinic, Qatar, 2019-2020
• Specialist Doctor: Internal Medicine, Istanbul Medipol University Hospital Mega Hospital Internal Medicine Department, 2020-2024
• Associate Professor Doctor: Internal Medicine, Istanbul Medipol University Medipol Acıbadem Regional Hospital, 2024-Present.

Roles in Projects:

Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.

Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.

Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.

Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).

Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.

Dr. Tülay Omma, Associate Professor

Specialization: Endocrinology and Metabolic Diseases

Academic Background

• Medical Education: İnönü University, Faculty of Medicine (English Program), 1994–2001.
• Internal Medicine Residency: Haseki Training and Research Hospital, 2004–2010.
• Subspecialty in Endocrinology and Metabolism: Ankara Training and Research Hospital, 2013–2017.

Professional Experience

• Clinical Expertise: 
  • General Practitioner with administrative responsibilities, 2002–2004.
  • Specialist in Internal Medicine during mandatory service, 2010–2013.
  • Endocrinologist and Metabolic Disease Specialist at Ankara Training and Research Hospital (2017–2023).
  • Earned the title of Associate Professor in 2023, reflecting her academic and clinical excellence.
    Lokman Hekim Health Group 2023 (present) 

Scientific Contributions & Publications

• Research Output: 
  • Published over 20 articles in peer-reviewed international journals, with a strong focus on diabetes, thyroid disorders, and polycystic ovary syndrome.
  • Delivered numerous oral presentations and posters at national and international conferences.
• Citation Metrics: 
  • Total Citations: 166
  • H-index: 6
  • i10-index: 4

Awards & Recognitions

• Multiple prestigious accolades, including: 
  • Best Oral Presentation Award (2023): For groundbreaking research on COVID-19 vaccines and Graves’ Disease.
  • Best Poster Award (2021): For clinical insights into hypoparathyroidism in Turkey (HiPOPARATURK-NET Study).

Professional Memberships & Certifications

• Active member of leading organizations: 
  • European Society of Endocrinology (ESE) and its Young Endocrinologists & Scientists Committee (EYES).
  • Turkish Society of Endocrinology and Metabolism.
• Completed numerous advanced training programs, including certifications in clinical trials, biostatistics, and thyroid ultrasonography.

Clinical & Research Focus

Dr. Omma’s expertise spans:

• Diabetes management and its complications.
• Advanced thyroid disease diagnosis and treatment.
• Polycystic Ovary Syndrome (PCOS) and its metabolic implications.
• Investigating the relationship between diet and endocrine/metabolic disorders.

Position:

Associate Professor ,

General Surgery Department

ISTANBUL MEDIPOL UNIVERSITY PENDIK HOSPITAL General Surgery Department

PERSONAL INFORMATION

Birth Date: 14.05.1982 

Place of Birth      : Şanlıurfa, Türkiye

Married, father of one.

CITIZENSHIP:

Republic of Turkey

EDUCATION:

Specialization:

General Surgery Department

Istanbul Kartal Dr. Lütfü Kırdar Training and Research Hospital (2009- 2014)

University

Istanbul University Istanbul Faculty of Medicine (20022008)

Anadolu University Faculty of Business Administration - Administration of Health Institutions (2013-2015)

Anadolu University Faculty of Open Education Department of Law (2016-)

High school

Erzincan Science High School (1998-2002)

Working Experience:

ERZINCAN NEVZAT AYAZ SCIENCE HIGH SCHOOL 1998-2002

ISTANBUL UNIVERSITY ISTANBUL FACULTY 2002-2009

GENERAL SURGERY ASSISTANT ISTANBUL KARTAL DR. LUTFI KIRDAR TRAINING AND RESEARCH HOSPITAL 2009-2014

SPECIALIST PHYSICIAN MEDENIYET UNIVERSITY GOZTEPE TRAINING AND RESEARCH HOSPITAL 2014-2015

CHIEF PHYSICIAN T.R.  MINISTRY OF HEALTH SILOPI STATE HOSPITAL 2015-2016

SPECIALIST PHYSICIAN T.R. MINISTRY OF HEALTH DERINCE TRAINING AND RESEARCH HOSPITAL, 2018-2020

SPECIALIST PHYSICIAN SANLIURFA MEHMET AKIF INAN TRAINING AND RESEARCH HOSPITAL 2016-2018

ASSOCIATE PROFESSOR ISTANBUL KARTAL DR. LUTFI KIRDAR CITY HOSPITAL 2020-2023

İSTANBUL MEDIPOL UNIVERSITY PENDIK HOSPITAL 2023-

PUBLICATIONS

National and International Articles

1 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2021). Inguinal hernia repair via laparoscopic transabdominal preperitoneal (TAPP) method: Our 2 years clinical results. Annals of Medical Research, 28(4), 812-815., Doi: 10.5455/annalsmedres.2020.05.443

2 SAĞIROĞLU ŞÜKRİYE JÜLİDE, ÖZDEMİR TUĞRUL, ATAK TUBA, GÖK MEHMET ALİ, ORHUN ERDOĞAN KIVILCIM, EREN TURGUT TUNÇ, ALİMOĞLU ORHAN (2016). Laparoscopic Total Extraperitoneal Inguinal Hernia Repair Without Mesh Fixation: Report of Early Outcomes. SouthernPrint Date :22/10/2022 17:41:41 Clinics of Istanbul Eurasia, 27(3), 215-219., Doi: 10.14744/scie.2017.64872 

3 ÇİFTÇİ ALİ, GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2022). Management of Acute Biliary Pancreatitis in Cholecystectomized Patients. Bezmiâlem Science, 10(4), 507-511. Doi: 10.14235/ bas galenos. 2021.6708

4 GÖK MEHMET ALİ, YEĞEN SERKAN FATİH, KAFADAR MEHMET TOLGA, KOCAOĞLU AYTAÇ EMRE (2022). Gastrointestinal Stromal Tümörlerde İmmünohistokimyasal Markırların ve Tümör Boyutunun Prognoz Üzerindeki Rolü. Kocaeli Tıp Dergisi, 10(2), 101-104. M-784-1650 KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2022). Laparoscopic transabdominal preperitoneal repair of strangulated femoral hernia: Superiority of an unusual emergency surgical approach due to a case. Annals of Medicine and Surgery, 36(1), 110-112.

5 GÖK MEHMET ALİ, KARADAYI BÜYÜKÖZSOY AYŞEGÜL, KAFADAR MEHMET TOLGA (2022). The sensitivity of ultrasound in the clinical diagnosis of inguinal hernias in adults: a comparative study. Journal of Ultrasound, 1-4., Doi: 10.1007/s40477-021-00641-4

6 KARADAYI BÜYÜKÖZSOY AYŞEGÜL, KARATAY EMRAH, GÖK MEHMET ALİ (2022). Comparison of the Effectiveness of Ultrasound Imaging and Perioperative Measurement in the Diagnosis and Characterization of Incisional Hernia. Journal of Medical Ultrasound, 1-5.

7 GÖK MEHMET ALİ, DEMİR MUSTAFA, YEĞEN SERKAN FATİH, KAFADAR MEHMET TOLGA, ŞENOL METİN, KOCAOĞLU AYTAÇ EMRE, AKIN EMRAH (2022). Endoscopic Intra-gastric Botulinum Toxin A for Obesity Treatment: IsIt Effective?. Kocaeli Tıp Dergisi, 11(2), 149-152.

8 GÖK MEHMET ALİ, KARATAY EMRAH, ÇİFTÇİ ALİ (2022). İnguinal Hernilerde Balonsuz ve Mesh Sabitleyicisiz Laparoskopik Total Ekstraperitoneal Onarımın Cerrahi Deneyim ile Korelasyonu. Dicle Medical Journal, 49(3), 498-503., Doi: 10.5798/dicletip.1170263

9 KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2022). Effects of Carvedilol on Liver İschemiaReperfusion İnjury in Rats. Ulusal Travma ve Acil Cerrahi Dergisi-Turkish Journal of Trauma & Emergency Surgery, 28(7), 885-893.

10 ŞENOL METİN, GÖK MEHMET ALİ (2022). Small Bowel Obstruction due to Phytobezoar. Kocaeli Tıp Dergisi, 11(2), 1-6.

11 KARATAY EMRAH, GÖK MEHMET ALİ, JAVADOV MIRKHALIG (2021). Measurement of hiatal surface area and other hiatus oesophageal diameters at computed tomography imaging in patients with gastroesophageal reflux disease and its relationship with hiatal hernia. Journal of Minimal Access Surgery, 17(4), 537-541., Doi: 10.4103/jmas.JMAS_175_20

12 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, YEĞEN SERKAN FATİH (2021). Perforated colorectal cancers; clinical outcomes \nof 18 patients who underwent emergency surgery. Gastroenterology Review, 16(2), 161-165., Doi: 10.5114/pg.2021.106667

13 YEĞEN SERKAN FATİH, KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2020). Comparison of Perioperative Standard and Immunomodulating Enteral Nutrition in Patients Received Major Abdominal Cancer Surgery: a Prospective, Randomized, Controlled Clinical Trial. Indian Journal of Surgery, 82, 828-834., Doi: 10.1007/s12262-020-02114-0 

14 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, YEĞEN SERKAN FATİH (2020). Effects of Preoperative Oral Carbohydrate Loading on Preoperative and Postoperative Comfort in Patients Planned to Undergo Elective Cholecystectomy: A Prospective Randomized Controlled Clinical Trial. Iranian Red Crescent Medical Journal, 22(11), 1-6., Doi: 10.32592/ircmj.2020.22.11.107

15 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, YEĞEN SERKAN FATİH (2019). Comparison of negative-pressure incision management system in wound dehiscence: A prospective, randomized, observational study. Journal of Medicine and Life, 12(3), 276-283., Doi: 10.25122/jml-2019-0033

16 KAFADAR MEHMET TOLGA, YALÇIN METİN, DADÜK YILDIRAY, SOYALP MURAT, GÖK MEHMET ALİ (2018). Laparoscopic Cholecystectomy for Acute Cholecystitis in Situs Inversus Totalis: An Extraordinary Approach. Eurasian Journal of Emergency Medicine, 17(2), 82-84.

17 KAFADAR MEHMET TOLGA, TEKER İBRAHİM, GÖK MEHMET ALİ, UĞURLU ESAT TAYLAN, ÇETİNKAYA ISMAİL (2018). Atraumatic splenic rupture secondary to abscess in a hemodialysis patient: a rare and fatal cause of acute abdomen diagnosed late. Journal of Surgical Case Reports,5, 1-3., Doi: 10.1093/jscr/rjy103

18 KAYA FERUDUN, KAFADAR MEHMET TOLGA, KISMET KEMAL, GÖK MEHMET ALİ, ERTAŞ ERTUĞRUL (2018). Congenital Transmesenteric Hernia Without Bowel Strangulation in a Young Adult. The Medical Bulletin Of Haseki, 56(4), 337-340., Doi: 10.4274/haseki.galenos.2022.8361

19 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, GÜNEŞ ABDULLAH (2018). Laparoscopic treatment of hepatic hydatid disease: Şanlıurfa-Turkey experience and early clinical outcomes. Laparoscopic Endoscopic Surgical Science, 25(3), 98-102., Doi:14744/less.2018.4353171203046744-1078.03 Basım Tarihi 22/10/2022 17:41:41 Sayfa: 2

20 KAFADAR MEHMET TOLGA, YALÇIN METİN, GÖK MEHMET ALİ, AKTAŞ AYŞEGÜL, YÜREKLİ TACİTTİN SEMİH, ARSLAN AYŞEGÜL İSAL (2017). intraparenchymal Leiomyoma of the Breast: A Rare Location for an Infrequent Tumor. intraparenchymal Leiomyoma of the Breast: A Rare Location for an Infrequent Tumor, 13(3), 156-168., Doi: 10.5152/ejbh.2017.3472

 21 GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA, ÖTER VOLKAN (2017). Early-term elective laparoscopic resection after endoscopic detorsion in cases with sigmoid colonic volvulus. Annals of Clinical and Analytical Medicine, 8(6), 492-495., Doi: 10.4328/JCAM.5231

22 KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ, ÖTER VOLKAN (2017). Late-diagnosed penetrating stab Wounds in diaphragm and herniation. Annals of Clinical and Analytical Medicine, 8(4), 367-369., Doi: 10.4328/JCAM.5103

23 ANADOLULU ALİ İHSAN, KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ, ANADOLULU ZEYNEP (2017). Laparoscopic spleen-preserving distal pancreatectomy with splenic vessel preservation for pancreatic pseudocyst in a 10-year-old boy. Journal of Pediatric Surgery Case Reports, 34(1), 10-12.

Proceedings

National and International Proceedings

İnguinal Hernilerde Total Ekstraperitoneal Onarımda Balon Disseksiyonu ile Teleskopik Disseksyonun   Kıyaslanması, KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2022). 22.. Ulusal Cerrahi Kongresi, 

İNSİZYONEL HERNİLERDE LAPAROSKOPİK VE KONVANSİYONEL ONARIM YÖNTEMLERİ ARASINDAPOSTOPERATİF AĞRI, GÖK MEHMET ALİ, JAVADOV MIRKHALIG (2021). 8.. Ulusal Fıtık Kongresi

Laparaskopık total ekstraperıitoneal (TEP) onarımında redükte edilemeyen keseler enerji

cıihazıyla lıigate edılebırlıir mı , KAFADAR MEHMET TOLGA, GÖK MEHMET ALİ (2019). 7..

Ulusal Fıtık Kongresi

TEK İNSİZYON LAPARASKOPİK TOTAL EKSTRAPERİTONEAL İNGUİNAL HERNİ ONARIMI DENEYİMİMİZ, GÖK MEHMET ALİ, DEMİR MUSTAFA (2019). 14.. Endoskopik Laparoskopik Cerrahi Kongresi

Laparaskopik Sleeve Gastrektomide 3D Görüntüleme Sisteminin Etkiniliği , GÖK MEHMET ALİ, KAYA FERUDUN, KAFADAR MEHMET TOLGA, AKSOY BAŞAR (2017). 2.. Bariatrik ve Metabolik Cerrahi Kongresi

İnsizyonel hernide laparaskopik preperitoneal onarım, GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2017).. 9.. Cerrahi Araştırma Kongresi

ERCP Yapılan Kist Hidatikli Hastalarda Kist Küçülür mü, YALÇIN METİN, GÖK MEHMET ALİ, KAFADAR MEHMET TOLGA (2017).. 13.. Türk Hepatopankreatobilier Cerrahi Kongresi

İnsizyonel Hernilerde TAPP Onarım Mümkün mü, GÖK MEHMET ALİ, AKSOY BAŞAR, KAFADAR MEHMET TOLGA, YALÇIN METİN (2017).. 6.. Ulusal Fıtık Kongresi, (Özet bildiri)

HİATAL HERNİLERDE LAPAROSKOPİK YAKLAŞIM, GÖK MEHMET ALİ, YALÇIN METİN, KAFADAR MEHMET TOLGA, YILMAZ TACETTİN SEMİH, AKTAŞ AYŞEGÜL (2017).. 13.. Endoskopik Laparoskopik Cerrahi Kongresi

KLİNİĞİMİZDE İNGUİNAL HERNİDE 3 TEKNİĞİN KARŞILAŞTIRLMASI, YALÇIN METİN, GÖK MEHMET ALİ, ÇEKİÇ TOLGA FARUK, KABALAK BİLAL, ÖTER VOLKAN, AKTAŞ AYŞEGÜL (2017). Ulusal Endoskopik Laparoskopik Cerrahi Kongresi

Kolon Divertikül  Perforasyonlarında Hartmann Prosedürü veya Primer Anastomoz? , GÖK MEHMET ALİ, KEŞKÜŞ BRAHIM H. HÜDAVERDI, BÖZKURT AHMET ÇAĞLAR, YALÇIN METİN, YILMAZ TACETTİN SEMİH (2017).. 11.. Ulusal Travma ve Acil Cerrahi Kongresi, (Özet bildiri)

GASTROİNTESTİNAL PREKANSEROZ LEZYONLARDA ENDOSKOPİK MUKOZAL REZEKSİYONUN ROLÜ, ORMAN SÜLEYMAN, GÖK MEHMET ALİ, EREN TURGUT TUNÇ, LEBLEBİCİ METİN, ALİMOĞLU ORHAN (2015). 12.. Ulusal Endoskopik Laparoskopik Cerrahi Kongresi

PİYES MAMAOGRAFİSİNDE KİTLE YOK! NE YAPILMALIM, ESER MEHMET, HATİPOĞLU HAYAT, GÜNDOĞAN ERSİN, GÖK MEHMET ALİ, ÇETİN KENAN, ACAR AYLİN, TAN SEDAT, BİLDİK NECDET (2014).. 19.. Ulusal Cerrahi Kongresi

LAPAROSKOPİK KOLESİSTEKTOMİ YAPILAN HASTALARDA TROKAR YERİ FITIĞI GELİŞİMİNDE ETKİLİ OLABİLECEK FAKTÖRLERİN ARAŞTIRILMASI, GÖK MEHMET ALİ, KÜNDEŞ MUHAMMED FİKRİ, KEMENT METİN, ATICI ALİ EMRE, KAPTANOĞLU LEVENT, İLHAN NOYAN, CAN UĞUR, BİLDİK NEJDET, VURAL SELAHATTİN (2014).. 19.. ULUSAL CERRAHİ KONGRESİ 

Books

Written sections in international books

1)Genel Cerrahide Nadir Görülen Acil ve Elektif Vakalar, Bölüm adı:(Akciğere Fistülize Karaciğer Kist Hidatik Vakasına Acil Laparoskopik Yaklaşım) (2020)., COŞKUN MURAT, GÖK MEHMET ALİ,

Akademisyen Yayınevi, Editör: Ender ANILIR Mehmet BAYRAK Mehmet Tolga KAFADAR Mert TANAL Ali Emre NAYCI Hüseyin KILAVUZ Özlem Öndeş BAYAR, Basım sayısı:1, Sayfa Sayısı 655, ISBN:978- 625-7275-23-1, Türkçe(Bilimsel Kitap)

2)Gastrointestinal Sistem Kanserlerinin Cerrahisi, Bölüm adı:(Karaciğerin Primer Solid MalignNeoplazileri) (2020)., GÖK MEHMET ALİ, Akademisyen Yayınevi, Editör: Hüseyin Özgür AYTAÇ, Basım sayısı:1, Sayfa Sayısı 404, ISBN:978-605-258-949-6, Türkçe (Bilimsel Kitap)

3)Gastrointestinal Sistem Tümörleri-1, Bölüm adı:(ERKEN EVRE HASTALIKTA CERRAHİ TEDAVİ) (2019)., GÖK MEHMET ALİ, Akademisyen Yayınevi, Basım sayısı:1, Sayfa Sayısı 493, ISBN:978-605-258-551-1, Türkçe (Bilimsel Kitap)

Editorship

1) Minimal İnvaziv Cerrahi, Kitap, Editör, Akademisyen Kitapevi A.Ş., 22.10.2020-15.07.2021

2. YENİ NESİLCERRAHİ, Kitap, Editör, Akademisyen Kitapevi A.Ş., 15.06.2021-15.08.2022

3. Onkolojik Cerrahi, Kitap, Editör, Akademisyen Kitapevi A.Ş., 05.04.2021-05.12.2021

4.. Fıtık Cerrahisi, Kitap, Editör, Akademisyen Kitapevi A.Ş., 07.04.2020-07.11.2020

Certificates

Hernia A to Z Fundemantals Hands on Workshop, Laparoscopic Hernia Surgery Experience Certificate in Cadaver was awarded by the European Hernia Society.

. DUBAİ/ U.A.E, 28.11.2018 

CADAVER TRAINING EVENT IN COLON AND RECTAL SURGERY, Robotic Colorectal Surgery in Cadaver training certificate was given.  STONY BROOK UNİVERSİTY / NEWYORK/ USA,.04.2016

Memberships in Scientific Organizations:

1.. Turkish Society of Colon and Rectum Surgery, Member, 2020

2.. Turkish Surgical Association, Member, 2014

Dr. Gonul Catli is a pediatric endocrinologist with over 20 years of experience. She specializes in childhood hormonal and metabolic disorders. Her areas of focus include diabetes, thyroid diseases, growth problems, and puberty issues. She received her training at Ankara University and Dokuz Eylul University. Dr. Catli has also worked as an Associate Professor at Izmir Katip Celebi University.

Dr. Catli is known for her scientific work and caring approach. She currently practices at Liv Hospital Ulus and Vadistanbul. She is a member of the European Society of Pediatric Endocrinology (ESPE) and several national associations. Dr. Catli is dedicated to using new treatments to support children’s health and well-being.

uzmanlık

Experience

Liman Hospital Radiology Clinic

Academy Medical Center

Anaclinic Medical Center

Kayseri State Hospital

Kayseri Erciyes University Radiology Clinic

Samsun Private Midiliv Medical Center

Samsun Büyük Anadolu Hospital (2023)

After the internal medicine examination, he also practiced in the United Kingdom, mainly treating patients with diabetes and endocrinological problems.

Diploma:

• 2002. Semmelweis University of Medicine General Medicine

Professional exam:

• 2007. Internal medicine
• 2014. Diabetology

Workplace

• 2015-2017 Mens Mentis Health Center
• 2017- EndoCare Endocrinology Center

Education

• Undergraduate: Faculty of Medicine, Istanbul University, 1993-1997
• M.Sc: Faculty of Medicine, Istanbul University, 1997-1999
• Specialization: Pediatrics, Ondokuz Mayıs University, 1999-2004
• Subspecialty: Pediatric Endocrinology, Ondokuz Mayıs University, 2004-2007
•  

Experience

• Ar.Gör. (Research Assistant): Ondokuz Mayıs University Faculty of Medicine, 1999-2004
• Research Assistant (Minor Research Assistant): Ondokuz Mayıs University Faculty of Medicine (Pediatric Endocrinology), 2004-2007
• Assist. Assoc. Dr.: Ondokuz Mayıs University Faculty of Medicine, 2007
• Uzm. Dr.: Gulhane Military Medical Academy (Military Service), 2007-2008
• Uzm. Dr.: Bakırköy Obstetrics and Gynecology Training and Research Hospital (Compulsory Service), 2008-2011
• Assoc: Bezmialem Vakif University Faculty of Medicine, 2011-2013
• Assoc. Dr.: Bezmialem Vakif University Faculty of Medicine, 2013-2018
• Prof. Dr.: Bezmialem Vakif University Faculty of Medicine, 2018-2023
• Prof. Dr.: Biruni University, 2023-
•  

Scientific Memberships

• National Pediatric Association
• Pediatric Endocrinology and Diabetes Association
•  

Awards

• Growth curves of Turkish girls with Turner syndrome: FAVOR Turner syndrome study group: 59th national pediatric congress 4-8 November 2015 ANTALYA PRIZE FIRST PRIZE FOR AN ORAL PRESENTATION
• Anthropometric findings and karyotype in Turner syndrome: National Turner syndrome database. 19TH UPEK 22-25 OCTOBER 2015. POSTER SECOND PRIZE
• Investigation of the Role of Irisin in the Pathophysiology of Puberty Precox in Female Rats. Esra Kutlu, İlker Tolga Özgen, Huri Bulut 24th UPEK Short Oral Presentation First Prize.
•  

Medical Interests

• -Growth Retardation
• -Puberty Problems (Early or Late Puberty)
• -Menstrual Irregularities in Adolescent Girls
• -Increased Hair Growth in Adolescent Girls
• -Diabetes
• -Obesity
• -Thyroid Problems
• -Pituitary Disorders
• -Genital Abnormalities
• -Micropenis and Gynaecomastia in Boys
• -Adrenal Gland Disorders

2014 : The world's first robotic oral thyroidectomy developed by Kim Hoon-yub

2011 ~ : Fellow of the International Society of Neuro Monitoring Research

2008 ~ : Permanent member of Korean Society of Endoscopic & Laparoscopic Surgeons

2008 ~ : Permanent member of Korean Society of Surgical Oncology

2008 ~ : Permanent member of the Asia Oceania Thyroid Association

2014 ~ : Research Professor, the Korean Society of Endoscopic & Laparoscopic Surgeons

2014 ~ : Member of planning Committee at the Korean Association of Thyroid and Endocrine Surgeons, member of the Medical Rights Advisory Committee

2012 ~ : Member of the International Surgery Research Forum

2015 ~ : Member of the American Thyroid Association

2015 ~ 2016: Research Professor, Division of Head and Neck Surgery, Johns Hopkins University School of Medicine, USA

Dr. Philipp Riss is the Team Leader in Surgical Endocrinology at the Medical University of Vienna. He specializes in general and visceral surgery. Dr. Riss earned his Doctorate in Medicine in 2005. He is a Senior Physician and a University Professor. He leads the Surgical Endocrinology Working Group. Dr. Riss has also organized several major international congresses.

He has received the Venia Docendi Award and the Sandoz Award for Thyroid Research. Dr. Riss is a member of leading societies, such as the European Society of Endocrine Surgeons and the International Society of Surgery. He also serves on advisory boards for neuroendocrine and endocrine surgery in Austria.

Dr. Mucahit Gur is an Internal Medicine Specialist. He focuses on Diabetes Mellitus, Hypertension, Obesity, Hyperlipidemia, and Thyroid Diseases. He received his medical degree from Cerrahpaşa Faculty of Medicine. He completed his specialization in Internal Diseases at Düzce University.

Dr. Gur has worked at Tokat Niksar State Hospital, Düzce University, and Tokat Zile State Hospital. He currently practices at Emsey Hospital. He is known for his expertise in metabolic and endocrine disorders. Dr. Gur uses evidence-based methods and is dedicated to providing high-quality care.

Prof Spiezia works for our private clinic in Naples, Clinica Ruesch. He is also the Head of the Endocrine Surgery Operative Unit at Ospedale del Mare Hospital, specializing in surgical procedures related to endocrine disorders, particularly thyroid and adrenal surgeries. He is also the Head of the Endocrine Surgery Regional Network, and consultant in the field of diagnostics and ultrasound-interventional therapy. 

Professor specializes in all endocrine pathologies with minimally invasive thyroid-saving interventions, on the parathyroids and lymph nodes, through video-assisted techniques, thermoablation with radio frequency for thyroid nodules, microwave thermoablation, and with laser.

He diagnoses the thyroid and lymph nodes by means of ultrasound-guided needle aspiration. Qualified as a robotic surgeon, coordinates training schools in endocrine ultrasound and has promoted various scientific meetings and training courses, emphasizing the care pathways for patients with thyroid pathologies. 

EDUCATION

Prof Stefano Spiezia holds a degree in Medicine and Surgery from the University of Naples, graduating cum laude in 1981. He specialized in Emergency Surgery at the same university, obtaining his diploma in 1986. In 1993, he completed a six-month specialization course in Minimally Invasive Surgery, followed by a managerial course in 1996 focused on healthcare organization management. He received accreditation for ultrasound units in 1997 and achieved a II level University Master’s Degree in Endocrine Surgery from the Seconda Università degli studi di Naples in 2007. This extensive educational background underscores his expertise in surgical practice and healthcare management.

PROFESSIONAL ACTIVITY

Stefano Spiezia has held several significant roles both in Italy and internationally, including:

• Head of the Endocrine Surgery Operative Unit, Naples, Italy
• Adjunct Professor at the University of Turin, Italy (2011-2025)
• Professor at Second University of Naples for Endocrine surgery, and Interventional diagnostics of the neck (1998-2014)
• Coordinator of the Training School at the Italian Society of Ultrasound in Medicine and Biology (SIUMB).
• Director and founder of the "Save Your Thyroid" International School of SIUMB, operating in Naples, Italy, and Cairo, Egypt
• Consultant in the Visiting Professor program at the Saudi German Hospital in Cairo, Egypt.
• Speaker and Organizer at various international congresses, including the ACTA Congress in Taipei, and the American Thyroid Association Congress in Chicago 

RESEARCH, PUBLICATIONS, MEMBERSHIP

Prof. Stefano Spiezia's research primarily focuses on endocrine disorders, particularly in the context of thyroid and adrenal surgeries: the development and application of minimally invasive surgical techniques, particularly for thyroid and adrenal surgeries, and is recognized as an expert in thermal ablation of the thyroid. 

In Clinical Trials, he is the Principal Investigator (PI) of the first in-human clinical trial (NP-TF-024) aimed at treating benign thyroid nodules, which highlights his commitment to advancing treatment options in endocrine surgery.

Stefano Spiezia is a member of several professional societies, including:

• Founder member of the EUROMIT in Minimally Invasive Thyroid Treatments
• American Thyroid Association: A leading organization focused on thyroid health and research.
• North American Society for Interventional Thyroidology: This society is dedicated to advancing the field of interventional thyroidology.
• Italian Society of Endocrine Surgery (SIUEC): He is a member and serves as a regional delegate in this society, which focuses on endocrine surgical practices in Italy.
• Italian Society of Ultrasound in Medicine and Biology (SIUMB): He is a member and currently serves as the General Secretary of this society, which promotes the use of ultrasound in medical practice

His  Editorial Roles:  Review Editor on the Editorial Board of Thyroid Endocrinology and a member of the Video Endocrinology editorial board in the ATA. 

Author of 7 books and 68 scientific publications.

His work has been cited 3,466 times across 2,256 documents, indicating a significant impact in his field.